[{"id":"555db657-4655-4862-bfa8-a2edf7c955d2","acronym":"","url":"https://clinicaltrials.gov/study/NCT03440437","created_at":"2021-01-18T16:58:08.110Z","updated_at":"2024-07-02T16:35:42.764Z","phase":"Phase 1/2","brief_title":"A Phase 1/2 Study of FS118 in Patients With Advanced Malignancies","source_id_and_acronym":"NCT03440437","lead_sponsor":"invoX Pharma Limited","biomarkers":" LAG3","pipe":"","alterations":" ","tags":["LAG3"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e paclitaxel • FS118"],"overall_status":"Active, not recruiting","enrollment":" Enrollment 95","initiation":"Initiation: 04/16/2018","start_date":" 04/16/2018","primary_txt":" Primary completion: 06/01/2024","primary_completion_date":" 06/01/2024","study_txt":" Completion: 06/01/2024","study_completion_date":" 06/01/2024","last_update_posted":"2023-07-18"}]